Skip to main content

Rapport Therapeutics, Inc.

RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002012593

In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Rapport Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+20 vs. Q2 2024
Shares held
28.4M
+2.89M (+11.3%) vs. Q2 2024
Total value
$581.9M
−$11.6M (−1.9%) vs. Q2 2024
New holders
30
11 more added
Sold out
10
7 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RAPP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 55 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 35 institutionsQ3 2024: 55 institutionsQ4 2024: 70 institutionsQ1 2025: 77 institutionsQ2 2025: 82 institutionsQ3 2025: 124 institutionsQ4 2025: 144 institutionsQ1 2026: 147 institutionsQ2 2026: 160 institutions
Value heldQ3 2024: $581.9M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $593.4MQ3 2024: $581.9MQ4 2024: $648.9MQ1 2025: $382.3MQ2 2025: $437.9MQ3 2025: $1.46BQ4 2025: $1.55BQ1 2026: $1.64BQ2 2026: $2.13B
Institutions holding RAPP and their total value by quarter
QuarterHoldersValue
Q2 2026160$2.13B
Q1 2026147$1.64B
Q4 2025144$1.55B
Q3 2025124$1.46B
Q2 202582$437.9M
Q1 202577$382.3M
Q4 202470$648.9M
Q3 202455$581.9M
Q2 202435$593.4M
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Rapport Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding RAPP in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC5,486,468$112.4M0.01%+503,117+10.1%Added
ARCH Venture Management, LLC3,728,738$76.4M29.31%00.0%Unchanged
Cormorant Asset Management, LP2,940,921$60.2M3.19%+6380.0%Added
Capital International Investors2,602,529$53.3M0.01%−20.0%Reduced
Johnson & Johnson2,498,051$51.2M11.97%00.0%Unchanged
Sofinnova Investments, Inc.1,995,594$40.9M3.38%+44,032+2.3%Added
T. Rowe Price Investment Management, Inc.1,727,111$35.4M0.02%+191,960+12.5%Added
Goldman Sachs Group Inc1,247,171$25.5M0.00%+1,247,171New
Alliancebernstein L.P.1,088,921$22.3M0.01%−1,937−0.2%Reduced
Price T Rowe Associates Inc1,047,408$21.5M0.00%−313,197−23.0%Reduced
Perceptive Advisors LLC748,183$15.3M0.33%00.0%Unchanged
BlackRock, Inc.576,118$11.8M0.00%+576,118New
Vanguard Group Inc506,767$10.4M0.00%+436,767+624.0%Added
Citadel Advisors LLC487,458$9.48M0.01%−105,000−17.7%Reduced
Siren, L.L.C.384,197$7.87M0.39%+384,197New
Geode Capital Management, LLC201,748$4.13M0.00%+201,748New
Logos Global Management LP208,910$4.06M0.46%00.0%Unchanged
Woodline Partners LP186,560$3.82M0.03%+15,460+9.0%Added
Eventide Asset Management, LLC110,401$2.26M0.04%+60,401+120.8%Added
Manufacturers Life Insurance Company, The77,344$1.58M0.00%+1,828+2.4%Added
Charles Schwab Investment Management Inc73,146$1.50M0.00%+73,146New
Northern Trust Corp72,212$1.48M0.00%+72,212New
Norges Bank70,000$1.43M0.00%00.0%Unchanged
TD Asset Management Inc62,198$1.33M0.00%−39,324−38.7%Reduced
State Street Corp58,046$1.19M0.00%+58,046New
Maven Securities LTD29,930$613.0K0.07%+29,930New
Morgan Stanley24,228$496.2K0.00%+24,228New
Winton Group Ltd24,127$494.1K0.03%+24,127New
LMR Partners LLP20,000$409.6K0.01%−30,000−60.0%Reduced
Bank of New York Mellon Corp19,970$409.0K0.00%+19,970New
Bank of America Corp19,110$391.4K0.00%+19,110New
Acuta Capital Partners, LLC17,600$360.4K0.29%−2,400−12.0%Reduced
Rhumbline Advisers15,843$324.5K0.00%+15,843New
Barclays PLC12,863$263.4K0.00%+3,463+36.8%Added
Citigroup Inc12,774$261.6K0.00%+12,774New
Nuveen Asset Management, LLC12,068$247.2K0.00%+12,068New
MetLife Investment Management5,710$116.9K0.00%+5,710New
UBS Group AG5,557$113.8K0.00%+2,430+77.7%Added
Mirae Asset Global ETFs Holdings Ltd.5,077$104.0K0.00%+5,077New
Sandia Investment Management LP5,000$102.4K0.17%00.0%Unchanged
Corebridge Financial, Inc.4,967$101.7K0.00%+4,967New
SG Americas Securities, LLC4,934$101.0K0.00%+4,934New
JPMorgan Chase & Co4,033$82.6K0.00%+4,033New
Wells Fargo & Company3,472$71.1K0.00%+3,472New
STRS Ohio1,700$34.8K0.00%+1,700New
BNP Paribas Arbitrage, SA1,684$34.5K0.00%+1,684New
Royal Bank of Canada1,472$31.0K0.00%+1,247+554.2%Added
Values First Advisors, Inc.1,507$30.9K0.02%+1,507New
Tidemark, LLC1,088$22.3K0.01%00.0%Unchanged
Ameritas Investment Partners, Inc.941$19.3K0.00%+941New
Legal & General Group Plc909$18.6K0.00%+909New
California State Teachers Retirement System685$14.0K0.00%+685New
Amalgamated Bank317$6.00K0.00%+317New
Tower Research Capital LLC (TRC)257$5.26K0.00%+257New
Sterling Capital Management LLC19$3890.00%+19New
Artal Group S.A.0$00.00%−350,000−100.0%Sold out
Millennium Management LLC0$00.00%−116,782−100.0%Sold out
Saturn V Capital Management LLC0$00.00%−70,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−40,000−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−34,731−100.0%Sold out
Soros Fund Management LLCSuperinvestorSoros Fund Management0$00.00%−30,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−16,345−100.0%Sold out
Two Sigma Investments, LP0$00.00%−13,000−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−10,000−100.0%Sold out
Davidson Kempner Capital Management LP0$00.00%−10,000−100.0%Sold out